The Microfluidic Biomolecular team is developing an integrated microfluidic system for simple and robust biomolecular amplification with an inexpensive reader to conduct a rapid and complicated analysis of a range of samples encountered in the field. They are targeting this microfluidic biomolecular amplification reader (MicroBAR) at global health diagnostics, with a specific focus on tuberculosis detection and classification based on drug resistant genotype. Funds will be used to return to South Africa to scale up their project for field deployment.